Inactivation of the Pseudomonas-Derived Cephalosporinase-3 (PDC-3) by Relebactam
is a prevalent and life-threatening Gram-negative pathogen. -derived cephlosporinase (PDC) is the major inducible cephalosporinase in In this investigation, we show that relebactam, a diazabicyclooctane β-lactamase inhibitor, potently inactivates PDC-3, with a / of 41,400 M s and a of 0.00095 s Rele...
Saved in:
Published in | Antimicrobial agents and chemotherapy Vol. 62; no. 5 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.05.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | is a prevalent and life-threatening Gram-negative pathogen.
-derived cephlosporinase (PDC) is the major inducible cephalosporinase in
In this investigation, we show that relebactam, a diazabicyclooctane β-lactamase inhibitor, potently inactivates PDC-3, with a
/
of 41,400 M
s
and a
of 0.00095 s
Relebactam restored susceptibility to imipenem in 62% of multidrug-resistant
clinical isolates, while only 21% of isolates were susceptible to imipenem-cilastatin alone. Relebactam promises to increase the efficacy of imipenem-cilastatin against
. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Citation Barnes MD, Bethel CR, Alsop J, Becka SA, Rutter JD, Papp-Wallace KM, Bonomo RA. 2018. Inactivation of the Pseudomonas-derived cephalosporinase-3 (PDC-3) by relebactam. Antimicrob Agents Chemother 62:e02406-17. https://doi.org/10.1128/AAC.02406-17. |
ISSN: | 0066-4804 1098-6596 |
DOI: | 10.1128/AAC.02406-17 |